Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 29,999	$ 25,154
Research and development credits	5,026	1,751
Stock-based compensation	1,132	1,295
Operating lease liabilities	7,466	583
Capitalized research & experimental expenditures	19,036	9,076
Deferred revenue	3,768	2,763
Other	920	474
Total gross deferred tax assets	67,347	41,096
Less: valuation allowance	(59,956)	(40,512)
Total deferred tax assets	7,391	584
Operating lease right-of-use assets	(7,391)	(584)
Total deferred tax liabilities	$ (7,391)	$ (584)